Spenlehauer Gilles

Director Spenlehauer bought 1,009 shares of CTCX at $0.51; stock now $0.47, down 90.4% from 52-week high.

Spenlehauer Gilles (Director) purchased 1,009 shares at $0.51 on 2024-09-06, increasing his holdings by 15.3% to 7,598 shares. The stock has since declined to $0.47, representing a -90.4% drawdown from its 52-week high of $4.87 and a 30-day decline of -55.2% from purchase. At the same ticker, his prior two buys in December 2023 each showed 90-day losses (-41.3% and -35.2%), with 0 of 2 prior CTCX buys proving well-timed over 90 days. Importantly, the company is unprofitable with latest-quarter revenue of $12,320.00 and a full-year net income of $-3,304,538.00, and a cluster of 5 other insiders also bought within the past 14 days. The convergence of sharply negative price momentum, unprofitable fundamentals, a failed timing pattern at this ticker, and coordinated multi-insider buying amid distress suggests elevated risk.

Director Spenlehauer buys 87 CTCX shares at $0.57; stock down 88.5% from 52-week high, 5-insider cluster pattern emerges.

Director Gilles Spenlehauer purchased 87 shares at $0.57 on 2024-08-30, the third consecutive buy in two days, as part of a 5-insider cluster buy pattern within the past 14 days. The transaction comes as CTCX stock has declined 88.5% from its 52-week high of $4.87 and has fallen 50.0% over the past 30 days and 78.4% over 90 days. At Spenlehauer's prior trades at this ticker (December 2023 and recent August 2024 purchases), 0 of 3 measurable buys showed positive 90-day returns; his three December trades posted 90-day declines of -41.3%, -35.2%, and -57.6%. Carmell remains unprofitable with negative full-year net income of $-3,304,538.00 and latest quarterly revenue of only $12,320.00, constraining fundamental support for the depressed share price.

Director Spenlehauer purchases 1,121 shares at $0.56 across 2 trades as stock falls 39.6% in 30 days; 6 other insiders also bought in past 14 days

Spenlehauer Gilles, a Director at Carmell Corp, filed 2 purchases totaling 1,121 shares for $627.76 (blended average $0.56) on 2024-08-28 and 2024-08-29, increasing his holdings from 5,381 to 6,502 shares (+20.8%). The timing is notable given sharply negative price momentum: the stock is down 39.6% over 30 days and 74.3% over 90 days, trading at $0.64 versus a 52-week high of $4.87. A cluster of 6 other insiders also purchased within the past 14 days, suggesting coordinated confidence or response to external conditions. However, context raises caution: Spenlehauer's prior 4 measurable trades at CTCX show 0 well-timed outcomes at the 90-day mark (each followed by declines ranging from 22.3% to 57.6%), and the company is unprofitable with a net loss of $-3,304,538.00 over its most recent full fiscal year. The current purchase occurs in a depressed price environment but lacks evidence of predictive accuracy from this insider's historical timing at this ticker.